We have previously shown that ischemic preconditioning (IPC) protection against necrosis in whole hearts and in both fresh and cultured cardiomyocytes, as well as the improved regulatory volume decrease to hypoosmotic swelling in cardiomyocytes, is abrogated through Cl Ϫ channel blockade, pointing to a role for enhanced cell volume regulation in IPC. To further define this cardioprotective mechanism, cultured rabbit ventricular cardiomyocytes were preconditioned either by 10-min simulated ischemia (SI) followed by 10-min simulated reperfusion (SR), by 10-min exposure/10-min washout of remote IPC (rIPC) plasma dialysate (from rabbits subjected to repetitive limb ischemia), or by adenoviral transfection with the constitutively active PKC-ε gene. These interventions were done before cardiomyocytes were subjected to either 60-or 75-min SI/60-min SR to assess cell necrosis (by trypan blue staining), 30-min SI to assess ischemic cell swelling, or 30-min hypoosmotic (200 mosM) stress to assess cell volume regulation. Necrosis after SI/SR and both SI-and hypoosmotic stressinduced swelling was reduced in preconditioned cardiomyocytes compared with control cardiomyocytes (neither preconditioned nor transfected). These effects on necrosis and cell swelling were blocked by either Cl Ϫ channel blockade or dominant negative knockdown of inwardly rectifying K ϩ channels with adenoviruses, suggesting that Cl Ϫ and K ϩ movements across the sarcolemma are critical for cell volume regulation and, thereby, cell survival under hypoxic/ischemic conditions. Our results define enhanced cell volume regulation as a key common mechanism of cardioprotection by preconditioning in cardiomyocytes.
cardiomyocytes; remote ischemic preconditioning; chloride channels; cell volume regulation; cell swelling; protein kincase C-ε CARDIOMYOCYTE SURVIVAL under conditions of ischemia/reperfusion (I/R) requires avoiding both necrosis and apoptosis, and it is increasingly recognized that necrosis is by far the dominant mode of I/R cell death after a single I/R episode (2) . Necrosis, according to the nomenclature committee on cell death, "is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents" (22) . During ischemia, metabolites (e.g., lactate) accumulate in cardiomyocytes, thereby increasing intracellular osmolarity and promoting cell swelling (26) . As ischemic cardiomyocytes approach irreversibly injury, they also develop cell membrane fragility due to weakening by proteases and lipases, such that they do not tolerate the mechanical forces imposed on the cell membrane by cell swelling (osmotic fragility). On reperfusion, cardiomyocytes are exposed to an extracellular milieu that creates an even greater transsarcolemmal osmotic gradient (estimated to be ϳ60 mosM) (19) leading to further cell swelling and necrotic (oncotic) cell membrane rupture/death (19) . Empirical support for this paradigm of I/R necrosis comes from reductions in acute cell swelling and infarct sizes observed when reperfusion involves hyperosmolar infusion (13, 15, 21) .
Ischemic preconditioning (IPC) triggers the activation of multiple signaling pathways resulting in reduced cardiomyocyte swelling during the long (index) period of myocardial ischemia and reperfusion, thus extending the duration of index ischemia that causes lethal cell swelling and, as a result, conferring myocardial protection (7) . Similar to IPC, selective activation of adenosine A 1 /A 3 receptors with N-6 -2(4-aminophernyl)ethyladenosine (APNEA) or stimulation of PKC with PMA, a phorbol ester known to directly activate PKC, has been shown to not only to protect cardiomyocytes against necrosis but also against cell swelling induced by hypoosmotic (200 mosM) stress (HS) under normoxic conditions (7, 10) . Translocation of PKC-ε induced by IPC or PMA has been shown to play an essential role in IPC (24) and remote IPC (rIPC) cardioprotection (25) . Both IPC and pharmacologically induced cardioprotection with APNEA and PMA are blocked by Cl Ϫ channel inhibition, supporting the notion that Cl Ϫ channels are downstream from cell membrane receptor and PKC signaling in IPC (3, 10) . Moreover, IPC and APNEA independently trigger similar Cl Ϫ effluxes (ϳ30 mM) that depend on Cl Ϫ channel activity (8) . Interestingly, reductions in inwardly rectifying K ϩ current (I K1 ) channels (17) with either barium blockade or dominant negative knockdown with adenoviruses also abolishes IPC protection against cell necrosis (12) . These observations suggest that both K ϩ and Cl Ϫ must be exported from cardiomyocytes to support the cell volume regulation needed for cardioprotection. However, a mechanistic link between enhanced cell volume regulation by IPC and I K1 channels remains to be determined. Also, it is unknown whether this enhanced cell volume regulatory mechanism is shared by other forms of preconditioning.
In this report, we show, for the first time, that 1) cardioprotection by rIPC and overexpression of constitutively active PKC-ε share a common end-effector mechanism involving the activation of sarcolemma Cl Ϫ channels with IPC, 2) cardio-protection by rIPC and overexpression of constitutively active PKC-ε are linked to each preconditioning protocol ability to enhance cell volume regulation via Cl Ϫ channel activation in cardiomyocytes, and 3) I K1 channels work in concert with Cl Ϫ channels to enhance cell volume regulation in preconditioned cardiomyocytes, thus substantially reducing HS-induced cell swelling under oxygenated conditions and reducing/preventing cell swelling during simulated ischemia. Isolation of adult cardiomyocytes. Ventricular cardiomyocytes were isolated from New Zealand White rabbit (weight range: 3.0 -3.5 kg) hearts by enzymatic digestion using a modified method as previously described (10) . Rabbits were initially anesthetized with pentobarbital (30 mg/kg) administered as a bolus dose via an intravenous catheter placed in an ear vein. Also, a single dose of heparin (200 IU/kg) was administered together with the pentobarbital bolus to prevent clot formation during surgery. After the chest of each animal was shaved, a second bolus of pentobarbital (30 mg/kg) was administered to induce deep anesthesia. Immediately after and before respiratory arrest ensued, an anterior sternotomy was performed, and the heart was excised while still beating. Each heart was then immediately suspended from its aortic stump attached to a glass perfusion cannula connected to a Langendorff apparatus and retrogradely perfused for 2-3 min with oxygenated HEPES-based buffer containing (in mM) 128.3 NaCl, 4.7KCl, 1.0 CaCl 2, 0.5 MgSO4, 1.2 KH2PO4, 10.0 NaHCO3, 10.0 D-glucose, and 20.0 HEPES (pH 7.4 at 37°C) supplemented with 0.1% BSA to wash out blood from the heart. Next, each heart was perfused with the same HEPES-based buffer containing only 20 M Ca 2Cl (Ca 2ϩ -free buffer) for 10 min to arrest the heart before perfusion with the same Ca 2ϩ -free buffer containing 200 IU/ml collagenase type II (Worthington, activity range: 275-285) and supplementation with 0.1% BSA to digest the heart. After digestion, each heart ventricle was minced in fresh collagenase containing Ca 2ϩ -free buffer, and cells were dissociated to obtain single cardiomyocytes by filtering the buffer through a mesh to separate isolated cardiomyocytes from undigested tissue and debris. After filtration, Ca 2ϩ -free buffer containing 2% BSA was added to cardiomyocytes to reduce enzymatic activity and allow centrifugation at 45 g for 3 min to separate the supernatant containing collagenase. This process was repeated twice to obtain a thorough washout of the collagenase. The concentration of Ca 2Cl in the buffer was then increased in five incremental steps 5 min apart to achieve a final total concentration of 1 mM. Only cell culture plates found with Ͼ70% of viable and Ca 2ϩ -tolerant cells were used in experiments.
MATERIALS AND METHODS

All
Primary culture of cardiomyocytes. After isolation, cardiomyocytes were cultured in 35-mm glass-bottomed laminin-coated petri dishes and incubated at 37°C in a humidified 5% CO 2-95% air mix environment for 48 h. Each dish contained 2 ml culture medium 199 with Earle's salts (GIBCO, Burlington, ON, Canada) supplemented with 10% FBS, 100 IU/ml penicillin, 10 M cytosine ␤-D-arabinofuranoside, 100 mg/ml streptomycin, and 0.08 mg/ml gentamicin, as we have previously reported (12) . Culture medium was replaced with freshly prepared medium after 24 h of incubation.
Characterization of cardiomyocyte volume changes in response to HS. We characterized the response of oxygenated (95% O 2-5% CO2) cardiomyocytes to a long period (120 min) of HS (200 mosM). Cells were incubated at 37°C in Tyrode buffer containing (in mM) 68 NaCl, 0.53 MgSO 4, 4.7 KCl, 25 NaHCO3, 1.2 KH2PO4, 1.2 CaCl2, and 10 D-glucose, with pH adjusted to 7.4 to determine the time course for cell volume regulation in untreated control cardiomyocytes and also in cardiomyocytes initially preconditioned by 10 min of simulated ischemia (SI) and 20 min of simulated reperfusion (SR). The percent cell volume change in response to HS was calculated from the changes measured in cardiomyocyte areas (by computer tracing) from images acquired before HS and after 8, 10, 12, 30, 60, 90, and 120 min of HS. Briefly, cardiomyocytes were placed on the stage of a motorized confocal microscope controlled by Volocity software equipped with a time-lapse recording feature. We only assessed cardiomyocytes that were well into focus and completely attached to laminin. Changes in cell volume were derived from the changes in cell area by applying a correction factor (cell area % change ϫ 2 ϭ cell volume % change) as previously determined (3) . The osmolarity of the isoosmotic solution was adjusted for the initial stabilization period to 300 mosM by adding mannitol. Both control and preconditioned cardiomyocytes reached maximum cell swelling within the first 8 -12 min of HS (peak cell swelling; Fig. 1 ). Both nonpreconditioned (control) and preconditioned (IPC) cardiomyocytes reached maximum cell swelling within the first 8 -12 min of HS (peak cell swelling; Fig. 1 ). Subsequently, in control (nonpreconditioned) cardiomyocytes, osmotic-induced cell swelling was substantially reduced between the time to peak swelling and 30 min of HS, and cell swelling was then subsequently more gradually reduced until cells achieved their pre-HS (isoosmotic conditions) cardiomyocyte volume after 120 min of HS ( Fig. 1) , as previously reported (3) . Similarly, in preconditioned (IPC) cardiomyocytes, osmotic-induced cell swelling was also substantially reduced within the first 30 min of HS (Fig. 1) . Because about half of the reduction in cell volume was observed at 30 min of HS, we opted for exposing cardiomyocytes to 30 min of HS in all subsequent experiments.
IPC experiments in cultured cardiomyocytes. After 48 h in culture, cardiomyocytes were initially stabilized for 30 min in medium 199 supplemented only with 0.1% BSA and kept at 37°C in an incubator. After stabilization, cardiomyocytes were ischemically preconditioned by incubating them in a hypoxic (PO 2 Ͻ 10 mmHg) HEPES-based solution (37°C) containing (in mM) 139 NaCl, 4.7 KCl, 0.5 MgCl2, 0.9 CaCl2, 5 HEPES, and 10 2-deoxy-D-glucose with 0.1% BSA at pH 7.4 (IPC buffer) for 10 min to simulate early ischemia in the whole heart followed by 20-min SR (incubation in oxygenated medium 199 with 0.1% BSA). Control cardiomyocytes were not preconditioned. Cardiomyocytes (IPC and control cells) were then subjected either to 30-min SI or to 60-min SI/60-min SR for the viability experiments (Fig. 2) . Prolonged ischemia was simulated by incubating cardiomyocytes at 37°C in a 100% N 2 atmosphere in hypoxic HEPES-based buffer similar to the IPC buffer but containing (in mM) 12 KCl and 20 DL-lactic acid (with pH adjusted to 6.5) for the purpose of simulating the advanced effects of ischemia in whole hearts. We first determined if IPC protection in cultured cardiomyocytes could be abolished by Cl Ϫ channel inhibition, as we have previously shown (7). We inhibited Cl Ϫ channels with indanyloxyacetic acid 94 (IAA-94; 50 M) given 10 min before and during SI (Fig. 2) . We have previously established this concentration of IAA-94 to inhibit cell volume regulation [regulatory volume decrease (RVD) after HS-induced cell swelling under normoxic conditions] in cardiomyocytes by ϳ75% (3) and to completely eliminate IPC-induced Cl Ϫ efflux in cardiomyocytes (8) . The percentage of dead cardiomyocytes was used to measure cell death in cultured cardiomyocytes. Cell death was measured at two time points: before the long SI and at the end of SR. We used trypan blue staining to distinguish dead cardiomyocytes (cells stained dark blue) from nonstained live cardiomyocytes. Using an inverted microscope equipped with a charge-coupled device camera controlled by a computer, color images from four to five randomly selected fields (ϫ200 magnification) were obtained and stored for subsequent analysis. In each experiment, at each time point, we counted at least 500 cardiomyocytes (dead ϩ live) to determine the percentage of dead cardiomyocytes using the following formula: percentage of dead cardiomyocytes ϭ [(total number of dead cardiomyocytes)/total number of cardiomyocytes] ϫ 100.
Furthermore, to examine the role that K ϩ channels may have in the enhanced cell volume regulatory mechanism we have previously suggested to be triggered by IPC (12), we transfected cultured cardiomyocytes with a genetically engineered dominant negative Kir2.1 (AdEGFPKir2.1DN) or Kir2.2 (AdEGFPKir2.2DN) mutant gene component of the I K1 channel, as previously reported (12), and determined if knockdown of IK1 channels blocks RVD in cardiomyocytes and abolishes IPC protection against ischemia-induced cell . Cardiomyocytes were preconditioned either by 10-min SI/10-min SR (IPC) or treatment with remote IPC (rIPC) dialysate for 10 min followed by 10-min washout before being subjected to the long SI/SR protocol. *Time point at which cardiomyocyte samples were taken for measurements of cell death. B: ischemic cell swelling and hypoosmotic cell swelling. After an initial 30 min of stabilization, all cells were subjected to either 30-min SI or 30-min HS (200 mosM). Cardiomyocytes were preconditioned by either 10-min SI/10-min SR or pretreatment for 10 min with rIPC dialysate followed by 10 min of washout before being subjected to either SI or HS. IAA-94 was administered 10 min before SI or HS. *Time points at which samples were obtained to measure changes on cell volume (before SI or HS; after 30-min SI; at 8-, 10-, and 12-min HS; and after 30-min HS).
swelling. Briefly, cardiomyocytes transfected with either dominant negative Kir2.1, dominant negative Kir2.2, or the reporter enhanced green fluorescent protein (EGFP) gene were either preconditioned with 10-min SI/10-min SR or not preconditioned before being subjected to 30-min SI. In these experiements, we measured the percent cell volume change at the end of 30-min SI. To assess the effect of I K1 knockdown on RVD, cultured cardiomyocytes were exposed for 30 min to the same oxygenated (95% O 2-5% CO2) hypoosmotic (200 mosM) Tyrode buffer indicated above, and the percent cell volume change calculated from the changes in cardiomyocyte areas were measured (by computer tracing) from images acquired before HS and after 8, 10, 12, and 30 min of HS. RVD was calculated by applying the following formula: RVD ϭ [(percent cell volume change at peak cell swelling Ϫ percent cell volume change after 30-min HS)/percent cell volume change at peak cell swelling], as previously described (3).
In the group of cardiomyocytes subjected to 30-min SI, cell volume was measured before SI and after 30-min SI using confocal microscopy techniques, as we have previously reported (3, 7) . Briefly, 10 min before long SI, cultured cardiomyocytes were loaded with the green fluorescence cytosolic dye calcein-AM (2 M). This fluorescent dye stains the cytosol of cardiomyocytes, thus making it possible to record confocal Z-stacked images to delineate the inside of the cell membrane and to measure, with relative accuracy, the cell length (y-axis), width (x-axis), and height (z-axis), from which the cell volume at each specific time point was mathematically estimated using the following formula: cell volume (in m 3 ) ϭ cell length (in m) ϫ width (in m) ϫ height (in m). The percent cell volume change was then calculated as follows: percent cell volume change ϭ [(cell volume at 30-min SI Ϫ cell volume at 0-min SI)/cell volume at 0-min SI] ϫ 100.
rIPC experiments in cultured cardiomyocytes. The cardioprotective effect of rIPC was evaluated in a 48-h cultured cardiomyocyte model of SI and SR as previously reported (25) . A schematic diagram of the experimental protocols is shown in Fig. 2 . After an initial stabilization period (30 min), cardiomyocytes were exposed for 10 min to rIPC dialysate (plasma dialysate obtained from blood taken immediately after in vivo anesthetized adult rabbits were remotely preconditioned by four consecutive cycles of 5-min hindlimb ischemia and 5-min reperfusion) followed by a 10-min washout period in culture medium 199 with 0.1% BSA for cell necrosis experiment or in isoosmotic (300 mosM) Tyrode buffer saturated with O2 by bubbling in a mixed gas (95% O2-5% CO2) for the cell volume regulation experiments. Control dialysates obtained from sham-operated adult rabbits were used to treat cardiomyocytes for comparison. Details of the methods used to process the plasma dialysate have been previously described in detail (25) . In these experiments, after treatment with rIPC or non-rIPC dialysate, cardiomyocytes were subjected either to 75-min SI followed by 60-min SR, as in the IPC experiments described above, or to 30-min HS (200 mosM) given by incubation of cardiomyocytes in hypoosmotic Tyrode buffer, as described above for the RVD experiments. To determine if Cl Ϫ channel activity is also required for rIPC cardioprotection, Cl Ϫ channels were inhibited with 50 M IAA-94 before and during either the long SI/SR or HS period. The percentage of dead cardiomyocytes was determined before SI and at the end of the SR period. Changes in cell volume were measured in cardiomyocytes before and during HS (at 8, 10, 12, and 30 min of HS) as indicated above.
Cardioprotection induced by overexpression of constitutively active PKC-. After 4 h in primary culture, cardiomyocytes were infected with recombinant, replication-deficient, adenovirus type 5 encoding, in a bicistronic construct, either the EGFP (3.6 ϫ 10 9 TCID50/cardiomyocyte) reporter gene alone or EGFP in combination with the constitutively active PKC-ε gene (AE5; 1.8 ϫ 10 6 TCID50/ cardiomyocyte). This mutant PKC-ε gene has an A ¡ E amino acid substitution at the pseudosubstrate domain (amino acid 159) that eliminates the interaction with the pseudosubstrate; thus, autoinhibition is removed, rendering the protein constitutively active. These viruses were a generous gift from Dr. Peipei Ping. The viral dose used for these experiments was selected based on dose-response experiments (multiplicity of infection) initially performed to find the dose, for each virus, that would yield high transfection efficiency (ϳ100%) without causing cellular toxicity after 48 h in culture (data not shown). The much greater expression of the phosphorylated form of PKC-ε in AE5-transfected cardiomyocytes compared with nontransfected cardiomyocytes was confirmed by Western immunoblot analysis in separate experiments using anti-phospho-PKC-ε antibodies (data not shown). After 48 h in culture, transfected and nontransfected cardiomyocytes were initially subjected to a standard 30-min stabilization period followed by either 30-min SI or 60-min SI/60-min SR (Fig.  2A) . To determine if Cl Ϫ channels were also involved in the cardioprotection induced by overexpression of constitutively active PKC-ε, we inhibited Cl Ϫ channels with 50 M IAA-94 before and during SI (Fig. 2B) . Changes in cell volume were measured before and after 30-min SI. The percentage of dead cardiomyocytes was determined before SI/SR and after 60-min SI/60-min SR.
Statistical analysis. After tests for data normality and homogeneity of variance, ANOVA followed by Scheffé's post hoc test was performed to demonstrate significant differences (P Ͻ 0.05) among groups and between two groups, respectively. Data are expressed as means Ϯ SE.
RESULTS
Protection against cell death after I/R injury. IPC reduced (P Ͻ 0.001) the percentage of dead cardiomyocytes after 60-min SI/60-min SR (Fig. 3A) . In addition, overexpression of constitutively active PKC-ε via adenoviral infection of a mutant PKC-ε gene also encoding the EGFP reporter gene (AE5) rendered cardiomyocytes protected against cell necrosis caused by 60-min SI/60-min SR (Fig. 3B) compared with control or myocytes overexpressing EGFP alone. Similar to IPC and AE5, pretreatment of cardiomyocytes with rIPC dialysate but not with non-rIPC dialysate significantly (P Ͻ 0.01) reduced the percentage of dead cardiomyocytes after 75-min SI/60-min SI (Fig. 4) . This IPC, AE5, and rIPC protection was completely abolished by administration of 50 M IAA-94, a pan-Cl Ϫ channel blocker, whereas it did not have any effect on either nonpreconditioned control, EGFP-overexpressing, or nonrIPC-subjected cardiomyocytes (Figs. 3 and 4) . Cardiomyocyte mortality did not change over time in each baseline cardiomyocyte group (cardiomyocytes with or without drug/vehicle incubated at 37°C for the duration of each experimental protocol; data not shown).
Protection against HS-induced cell swelling in cardiomyocytes. Cardiomyocytes overexpressing the constitutively active PKC ε-isoform swelled in response to HS (200 mosM) to a much lower degree (at peak cell swelling) compared with cardiomyocytes that overexpressed EGFP alone (Fig. 5A ). Similar to cardiomyocytes that overexpressed EGFP alone, untransfected control cardiomyocytes significantly (P Ͻ 0.001) swelled in response to HS (Fig. 5A ). This protection against HS-induced cell swelling observed with the overexpression of PKC-ε was blunted (P Ͻ 0.0001) by inhibition of Cl Ϫ channels with 50 M IAA-94 (Fig. 5A) . Furthermore, rIPC dialysate treatment reduced (P Ͻ 0.0001) cell swelling in cardiomyocytes compared with control, and this reduction in cell swelling was blunted (P ϭ 0.012) by inhibition of Cl Ϫ channels with 50 m IAA-94 (Fig. 6A) . Interestingly, no differences were observed in RVD in cardiomyocytes that overexpressed PKC-ε compared with cardiomyocytes that overexpressed EGFP alone (Fig. 5B) . Similarly, no differences were observed in RVD in remotely preconditioned cardiomyocytes compared with nonpreconditioned cardiomyocytes (Fig. 6B) . To determine the participation of I K1 channels in cardiomyocyte cell volume regulation, we assessed the effect of HS in cardiomyocytes that expressed dominant negative Kir2.1 and Kir2.2 genes compared with expression of EGFP alone. Knockdown of I K1 via mutation of Kir2.1 or Kir2.2 significantly (P Ͻ 0.0001) blocked RVD in oxygenated cardiomyocytes (Fig. 7) .
Protection against ischemia-induced cell swelling in cardiomyocytes.
Cardiomyocytes that overexpressed the constitutively active PKC ε-isoform (Fig. 8A ) and cardiomyocytes subjected to IPC (Fig. 8B) were protected against the cell swelling otherwise observed in control cardiomyocytes after 30-min SI. Inhibition of Cl Ϫ channel activity with 50 M IAA-94 abolished (P Ͻ 0.001) the protection against ischemia-induced cell swelling in cardiomyocytes that overexpressed PKC-ε (Fig. 8A) , whereas knockdown of I K1 channels by either overexpression of dominant negative Kir2.1 or Kir2.2 genes abolished (P Ͻ 0.001) the IPC protection against ischemia-induced cell swelling without affecting cell swelling in control cardiomyocytes (Fig. 8B) . Furthermore, ethanol [0.03% (vol/vol)], used to dissolve IAA-94, had no effect on ischemia-induced cell swelling.
DISCUSSION
In the present study, we demonstrate that either IPC (either local or remote) or preconditioning by expressing constitutively active PKC-ε after adenoviral transfection of a genetically engineered PKC-ε gene provides substantial protection against necrosis induced in 48-h cultured adult rabbit ventricular cardiomyocytes by long (index) SI followed by SR. Furthermore, we demonstrate that each one of these modalities of preconditioning prevents cell swelling in cultured cardiomyocytes under the same conditions of SI used to induce necrosis and substantially reduces cell swelling induced by HS under nonischemic conditions. These preconditioning cardioprotective effects are blocked by pharmacological inhibition of Cl Ϫ channels with the pan-Cl Ϫ channel inhibitor IAA-94. Similarly, in this study, we demonstrate that knockdown of I K1 channels by adenoviral transfection of dominant negative Kir 2.1 or Kir2.2 genes in 48-h cultured cardiomyocytes blocks the cardioprotection by preconditioning against both SI-induced and HS-induced cell swelling. These experiments not only demonstrate that Cl Ϫ channel-mediated enhancement of cardiomyocyte volume regulation is a common end-effector cardioprotective mechanism shared by different preconditioning mo- 4 . rIPC protection in cultured cardiomyocytes. Cardiomyocytes were preconditioned by pretreatment with rIPC dialysate for 10 min followed by 10 min of washout before being subject to 75-min SI/60-min SR. The percentage of dead cardiomyocytes substantially increased after long SI/SR in untreated control cardiomytes, control cardiomyocytes treated with the Cl Ϫ channel blocker IAA-94, or cardiomyocytes treated with non-rIPC dialysate. However, rIPC dialysate significantly reduced the percentage of dead cardiomyocyte after long SI/SR. This rIPC dialysate protection was completely abolished by inhibition of Cl Ϫ channels with 50 M IAA-94. All data are expressed as means Ϯ SE; n ϭ 6 -8/group. *P Ͻ 0.0001 vs. untreated control, rIPC dilysate ϩ IAA-94, control ϩ IAA-94, or non-rIPC dialysate; **P ϭ 0.32 vs. non-rIPC dialysate.
dalities (e.g., IPC, rIPC, and expression of constitutively active PKC-ε) but also establish the mechanistic link between Cl Ϫ and I K1 channels in this cell volume regulatory response in cardiomyocytes. These results define the role of enhanced cell volume regulation in cardiomyocyte protection against I/Rinduced necrosis by preconditioning.
Particularly important are the parallel observations of inhibition of both cell volume regulation under normoxic and hypoxic/ischemic conditions with restriction of either Cl Ϫ or K ϩ movement across the sarcolemma. The novel I K1 results from the present study build substantively on our work with Cl Ϫ channel inhibition. They support the parallel effects with either a cation or anion, linked through charge balance across the cell membrane, based on the molecular specificity of the I K1 knockdown methodology of cardiomyocyte transfection and the location of I K1 limited to the cell membrane. Furthermore, the effects of IPC or constitutively active PKC-ε overexpression on cell swelling under SI are substantial. Instead of swelling, cardiomyocytes exhibited, on average, a reduction in cell volume of ϳ5% through 30 min in response to IPC (Fig.  8B) or constitutively active PKC-ε overexpression (Fig. 8A ) in contrast to the cardiomyocyte volume increase of 20% or more under either control conditions (no protection) or with blockade of either Cl Ϫ channel activity by IAA-94 (Fig. 8A) or I K1 channel inhibition by either dominant negative Kir 2.1 or Kir 2.2 overexpression (Fig. 8B) . We have previously demonstrated the same pattern of cell volume reduction, instead of swelling, under identical conditions of SI with IAA-94 panCl Ϫ channel inhibition in the context of IPC (7).
In the present study, we also demonstrate that rIPC of the myocardium by the practical approach of repetitive brief cycles of limb I/R, which is similar to IPC in being mediated in part by PKC-ε (25), involves improved cardiomyocyte volume in untreated controls. Pretreatment of cardiomyocytes with 10-min exposure to rIPC dialysate followed by 10 min of washout significantly reduced the HS-induced cell swelling (at peak cell swelling). Inhibition of Cl Ϫ channels with 50 M IAA-94 blocked the protection of rIPC dialysate against HSinduced cell swelling while having no effect on control cardiomyocytes. *P Ͻ 0.0001 vs. control or P ϭ 0.012 vs. rIPC ϩ IAA-94; **P ϭ 0.94 vs. control and P ϭ 0.08 vs. rIPC ϩ IAA94. B: graph showing the corresponding RVD values calculated from the data shown in A. Average RVDs in all groups ranged from 34.2 to 48.5. Cardiomyocyte RVDs were not affected by either rIPC alone or in combination with IAA-94 (rIPC ϩ IAA-94). RVDs were significantly inhibited by IAA-94 in nonpreconditioned (C ϩ IAA94) compared with untreated cardiomyocytes (control). All data are expressed as means Ϯ SE; n ϭ 29 -33 cells/group, N ϭ 3 hearts. *P ϭ 0.0011 vs. control; **P ϭ 0.5233 vs. control; †P ϭ 0.6726 vs. rIPC. regulation, as evidenced by the dialysate of blood plasma containing the active factor(s) released into the circulation by replicated limb I/R reducing hypoosmotic-induced cardiomyocyte swelling under normoxic conditions (Fig. 6) and that the protection of this dialysate against cultured cardiomyocyte necrosis by SI/SR being abrogated by pan-Cl Ϫ channel blockade with IAA-94 (Fig. 4) . We have not performed parallel experiments on the effects of I K1 knockdown by cardiomyocyte transfection on rIPC, which we have done with IPC for the following end points: 1) cultured cardiomyocyte necrosis (12) and 2) cardiomyocyte swelling under conditions of SI (7). However, we have shown that I K1 knockdown does reduce RVD in response to hypoosmotic swelling in cardiomyocytes (Fig. 7) . Furthermore, PKC-ε has been well established to play a key role in mediating the protection of both IPC (3, 24) and rIPC (16, 25) , and, in the present study, we have demonstrated both cardiomyocyte protection from overexpression of the constitutively active PKC ε-isoform (Fig. 3) and, moreover, the prevention of cardiomyocyte swelling under conditions of SI (Fig. 8A ) with essentially identical results to those with I K1 channel knockdown of IPC protection under the same experimental conditions (Fig. 8B) . Thus, the volume regulation theme underlying cardiomyocyte I/R injury extends from IPC to rIPC.
Multiple Cl Ϫ channels exist as end-effector candidates for IPC and rIPC protection, including ClC-2, ClC-3, CFTR Cl Ϫ , and swelling-activated Cl Ϫ channels [which may be ClC-3 based on cardiac-specific inducible ClC-3 gene deletion eliminating native volume-sensitive Cl Ϫ channels in adult mice (29) ]. Under ischemic conditions, cardiomyocytes depolarize to close to the resting potential at which all these Cl Ϫ channels export Cl Ϫ from the cell and, thus, may all be involved to some extent in cardiomyocyte volume changes under I/R conditions. ClC-2 channels expressed in Xenopus oocytes not only export Cl Ϫ in response to osmotic swelling but also due to low pH (20) , which is relevant to ischemic conditions. The swellingactivated Cl Ϫ channel has been extensively studied in cardiomyocytes and is regulated by PKC, PKA, and tyrosine kinase activity as well as governed by ROS (4). We have discovered colocalization of both ClC-2 and ClC-3 in a multiprotein complex with PKC-ε, Src kinase, and phosphatidylinositol 3-kinase (9, 23) , and all these kinases are linked to IPC cardioprotection. The CFTR Cl Ϫ channel is not volume regulated but is regulated by PKA and PKC in combination (18) , similar to IPC. Indeed, homozygous CFTR Ϫ/Ϫ mice prevent IPC protection against myocardial I/R (6). Thus, there is further supporting evidence for sarcolemmal Cl Ϫ channels in cardioprotection from I/R injury, and examining the relative contributions of the above Cl Ϫ channels is a subject for future investigation.
In the present study, we measured changes in cardiomyocyte area and converted these changes to cell volume changes by applying a correction factor we have previously determined (3). Using this approach, we confirmed our previous observations that adult rabbit cardiomyocytes reach a peak cell swelling between 8 and 12 min and subsequently undergo a substantial RVD after 30 min of exposure to a normoxic hypoosmotic buffer. Our observations confirm previous observations of two independent groups who observed RVD under similar experimental conditions in both rabbit ventricular myocytes (27) and neonatal rat cardiomyocytes (28) . In contrast, Bell et al. (5) , in a limited study, detected RVD in 2 of 12 freshly isolated neonatal rat cardiomyocytes and in 5 of 8 neonatal rat 48-h cultured cardiomyocytes and also could not detect RVD in mouse cardiomyocytes, all during 15 min of hypoosmotic challenge. Their inconsistent observations on RVD may be explained by their limited observation period of 15 min. If peak swelling occurs at 8 -12 min under hypoosmotic conditions, as we have observed, then an additional 3-7 min is too little time to reliably observe RVD. Building on the previous evidence supporting RVD in cardiomyocytes (27, 28) , our observations of an enhancement of the ability of cardiomyocytes to limit HS-induced cell swelling with preconditioning and blockade of this by inhibition of Cl Ϫ channels further support an operative RVD mechanism in cardiomyocytes.
Our cardiomyocyte model of SI followed by SR has inherent limitations. Ischemia is simulated by a combination of severe hypoxia (100% nitrogen environment) combined by glucose deprivation (replacement of glucose by osmotically equivalent 2-deoxyglucose) and surrounding the cardiomyocytes with an extracellular environment similar to the interstitium of myocardium after prolonged ischemia with pH 6.5, a lactate concentration of 20 mM, and a K ϩ concentration of 12 mM. This is not as effective as simulating no-flow ischemia by using a pellet of cardiomyocytes separated from O 2 by an oil diffusion barrier, as we have previously reviewed (11) . The close packing of pelleted cardiomyocytes mimics the limited extracellular space of the myocardium, forcing the intracellular buildup of metabolites under hypoxic/anoxic conditions. In contrast, in the cell culture plate cardiomyocytes are immersed in an almost infinite ratio of bathing medium compared with collective volume of the cardiomyocytes. We have demonstrated the protection of both IPC (3, 10) and rIPC (25) in freshly isolated ventricular cardiomyocytes using 30-min SI, but to produce similar percentages of cardiomyocyte necrosis in the two models, 60 -75 min of SI are required in cultured cardiomyocytes (11) . This is a good indication that the cell culture setting is probably limited to mimicking low-flow ischemia rather than no-flow ischemia. This tends to result in greater cardiomyocyte swelling due to the greater availability of extracellular water. From the perspective of IPC or constitutively active PKC-ε expression inhibition of cardiomyocyte swelling, the results are arguably even more impressive than if no-flow ischemia, which inherently limits cardiomyocyte swelling, could somehow be simulated in cell culture. With regard to translating our findings on the dramatic effect of IPC to not only prevent cardiomyocyte swelling but even reduce mean cardiomyocyte volume under conditions of SI to the myocardium in vivo, Askenasy and Navon (1) found that mean intracellular volume assessed by nuclear magnetic resonance spectroscopy in hearts decrease with three consecutive cycles of brief ischemia and reperfusion. As a practical matter, it is not possible to repetitively observe through the microscope the same cardiomyocyte in samples pipetted from the cardiomyocyte pellet for assessment, as the cells are subject to Brownian motion. Only on cardiomyocytes adherent to the culture plate can repetitive observations, such as those to estimate cell volume, be made (11) . It is also true that isolated cardiomyocytes, whether fresh or in cell culture, are unattached to each other and cannot completely reproduce events during reperfusion in intact hearts, in particular hypercontracture, which can mechanically rupture the cell membranes of cardiomyocytes, as we have previously acknowledged (7, 11) . Hypercontracture is a particular challenge because of the difficulty in determining in any particular cardiomyocyte whether it has occurred subsequent to or has preceded sarcolemmal breakdown. While subject to some limitations, it is fair to state that experiments on isolated cardiomyocytes have generally reproduced the results on cardiomyocyte necrosis in whole hearts of a wide variety of interventions exploring cellular mechanisms of preconditioning protection (11) . We have demonstrated that, under normoxic conditions, cardiomyocytes are able to ultimately neutralize an osmotic gradient of ϳ100 mosM (from exposure to a 200 mosM buffer) by adjusting cell volume back down to preswelling (baseline) conditions (Fig. 1) . This is important because Jennings et al. (19) estimated the osmolar load from prolonged cardiac ischemia associated with necrosis on reperfusion at ϳ60 mosM. Thus, at least under normoxic conditions, cardiomyocytes have the capacity to neutralize this osmotic load.
There is increasing osmotic fragility of the cardiomyocyte cell membrane with ongoing ischemia (14) . On reperfusion, the interaction of the osmolar load accumulated in the cardiomyocyte during ischemia with the unlimited availability of water on reperfusion support further cardiomyocyte swelling (19) . Taken together with cell membrane fragility, this is a recipe for cell membrane rupture. In this context, it seems reasonable that IPC, or rIPC, by improving cell volume regulation through kinase stimulation of sarcolemmal Cl Ϫ channel activity, thus impeding cardiomyocyte swelling, could delay the time at which a critical combination of swelling and membrane fragility result in membrane rupture and, thereby, cell necrosis. It is important to consider that there is a delay between kinase stimulation of IPC or rIPC and the long (index) ischemia. This delay allows a cardiomyocyte to be primed to produce much greater Cl Ϫ efflux than it would under control conditions, as we have previously measured in response to SI (8), thus greatly reducing peak swelling.
Our I K1 knockdown results in the present study, obtained by specific molecular targeting of this K ϩ channel, thereby limiting the potential efflux of K ϩ , the key counter ion to Cl Ϫ (the efflux of which is produced by IPC and blocked by IAA-94) (8) , are of particular relevance. This is because they not only show that prevention by IPC of cell swelling-induced by SI (Fig. 8B ) is abolished if a concurrent efflux of K ϩ is prevented by disabling I K1 but also that I K1 knockdown blunts the RVD to HS (Fig. 7) . These observations mirror the same results for IAA-94 blockade of Cl Ϫ transport previously observed the same cultured cardiomyocyte model we have previously characterized (7, 12) . Although IAA-94 inhibits Cl Ϫ channels from the outer side of the cell membrane, it is possible that it could have interacted with mitochondrial anion channels under our experimental conditions. Since the I K1 channel only exists in the cell membrane, and not in the mitochondria, the I K1 knockdown experiments presented in the present study avoid the issue of inadvertent drug interactions with mitochondria.
In summary, preconditioning of cardiomyocytes enhances a Cl Ϫ channel-dependent cell volume regulatory mechanism that is already in motion at the time cardiomyocytes become ischemic, or are exposed to a hypoosmotic challenge, resulting in reduced swelling as a major mechanism through which preconditioning acts to reduce cardiomyocyte necrosis in the context of I/R injury. The relative contributions of particular Cl Ϫ channels to this protection will be the subject of future investigation.
